FloBiotech is an early stage biotech company using advanced human brain cell models to develop disease-modifying therapeutic and diagnostic candidates to cure Alzheimer’s disease (AD). Our proprietary cell models (FloCells) will accelerate the search for and creation of effective treatments to transform Alzheimer's drug discovery and development (and other Tauopathies). The powerhouse team brought together at FloBiotech has the expertise, the vision, and the revolutionary technology to deliver transformative results and save the lives of the people we love.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Basel, Ch
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Tauopathies, Alzheimer’s disease, Neurodegeneration, Dementia, PSP, CTE, Parkinson’s disease, Disruptive Technology, CNS, Diagnostics, Drug Discovery, Drug Development.
- HQ
- Basel
Flobiotech Questions
Flobiotech's LinkedIn profile is https://ch.linkedin.com/company/flobiotech
Flobiotech has
6 employees.
View email and phone details for 6
employees at Flobiotech.
Flobiotech's industry is
Biotechnology Research
Flobiotech's top competitors are
Abbvie,
Algenscribe Sas,
Cementic,
Norgine,
Sumitomo Pharma Switzerland,
Biolabs France,
Papilio.bio,
Deltawave,
Biolabs,
Ispiron Biotechnologies.
Flobiotech's categories are Biotechnology Research
Flobiotech's founding year is 2024
